Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Activation of an unfolded protein response during differentiation of antibody-secreting B cells.

Gass JN, Gifford NM, Brewer JW.

J Biol Chem. 2002 Dec 13;277(50):49047-54. Epub 2002 Oct 8.

2.

Gene expression profiles of poor-prognosis primary breast cancer correlate with survival.

Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaïde J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, Houlgatte R.

Hum Mol Genet. 2002 Apr 15;11(8):863-72.

PMID:
11971868
3.

Gene expression profiling predicts clinical outcome of breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH.

Nature. 2002 Jan 31;415(6871):530-6.

PMID:
11823860
4.

Molecular classification of primary breast tumors possessing distinct prognostic properties.

Iwao K, Matoba R, Ueno N, Ando A, Miyoshi Y, Matsubara K, Noguchi S, Kato K.

Hum Mol Genet. 2002 Jan 15;11(2):199-206.

PMID:
11809729
5.

IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA.

Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D.

Nature. 2002 Jan 3;415(6867):92-6. Erratum in: Nature 2002 Nov 14;420(6912):202.

PMID:
11780124
6.
7.
8.

BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.

Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R.

J Cell Biol. 2001 Dec 10;155(6):911-21. Epub 2001 Dec 10.

9.
10.

Predicting the clinical status of human breast cancer by using gene expression profiles.

West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11462-7. Epub 2001 Sep 18.

11.

ER beta inhibits proliferation and invasion of breast cancer cells.

Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F.

Endocrinology. 2001 Sep;142(9):4120-30.

12.

A SAGE (serial analysis of gene expression) view of breast tumor progression.

Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K.

Cancer Res. 2001 Aug 1;61(15):5697-702.

13.

Plasma cell differentiation requires the transcription factor XBP-1.

Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH.

Nature. 2001 Jul 19;412(6844):300-7.

PMID:
11460154
14.

Nuclear hormone receptors and gene expression.

Aranda A, Pascual A.

Physiol Rev. 2001 Jul;81(3):1269-304. Review.

16.

Identification and characterization of estrogen receptor variants in prostate cancer cell lines.

Ye Q, Chung LW, Cinar B, Li S, Zhau HE.

J Steroid Biochem Mol Biol. 2000 Dec 1;75(1):21-31.

PMID:
11179905
17.

Gene expression profiling of primary breast carcinomas using arrays of candidate genes.

Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adélaïde J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B, Birnbaum D, Nguyen C.

Hum Mol Genet. 2000 Dec 12;9(20):2981-91.

PMID:
11115842
18.

Regulation of the functional interaction between cyclin D1 and the estrogen receptor.

Lamb J, Ladha MH, McMahon C, Sutherland RL, Ewen ME.

Mol Cell Biol. 2000 Dec;20(23):8667-75.

19.

Rho GTPases as modulators of the estrogen receptor transcriptional response.

Su LF, Knoblauch R, Garabedian MJ.

J Biol Chem. 2001 Feb 2;276(5):3231-7. Epub 2000 Nov 1.

20.

Identification of a novel FAS/ER-alpha fusion transcript expressed in human cancer cells.

Ye Q, Chung LW, Li S, Zhau HE.

Biochim Biophys Acta. 2000 Oct 2;1493(3):373-7.

PMID:
11018265

Supplemental Content

Support Center